These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Ways and prospects of producing gonococcal vaccine]. Bednova VN; Dmitriev GA; Pasternak NI Vestn Dermatol Venerol; 1987; (11):41-7. PubMed ID: 3125694 [No Abstract] [Full Text] [Related]
7. The primary sequence and antigenic structure of gonococcal pilin: approaches towards a gonococcal vaccine. Rothbard JB; Schoolnik GK Adv Exp Med Biol; 1985; 185():247-73. PubMed ID: 2416202 [No Abstract] [Full Text] [Related]
8. Development of a gonorrhoea vaccine: prospects, strategies and tactics. Gotschlich EC Bull World Health Organ; 1984; 62(5):671-80. PubMed ID: 6150769 [TBL] [Abstract][Full Text] [Related]
9. Preliminary studies on the development of a gonococcal vaccine. Greenberg I; Diena BB; Kenny CP; Znamirowski R Bull World Health Organ; 1971; 45(4):531-5. PubMed ID: 5004708 [No Abstract] [Full Text] [Related]
10. Neisseria gonorrhoeae: stability of typing markers after natural transmission. Copley CG; Chiswell CP; Egglestone SI Br J Vener Dis; 1983 Aug; 59(4):237-41. PubMed ID: 6409344 [TBL] [Abstract][Full Text] [Related]
11. Characterization of a gonococcal cell-wall lectin-adhesin with vaccine potential. Perrollet H; Guinet RM Ann Sclavo Collana Monogr; 1986; 3(1-2):399-406. PubMed ID: 3122804 [No Abstract] [Full Text] [Related]
12. MetQ of Neisseria gonorrhoeae Is a Surface-Expressed Antigen That Elicits Bactericidal and Functional Blocking Antibodies. Semchenko EA; Day CJ; Seib KL Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895130 [TBL] [Abstract][Full Text] [Related]
13. Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development. Edwards JL; Jennings MP; Apicella MA; Seib KL Crit Rev Microbiol; 2016 Nov; 42(6):928-41. PubMed ID: 26805040 [TBL] [Abstract][Full Text] [Related]
15. Detection of Neisseria gonorrhoeae in broth cultures by immunologic methods. Lue YA; Ellner PD Sex Transm Dis; 1978; 5(1):14-7. PubMed ID: 417408 [TBL] [Abstract][Full Text] [Related]
16. Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea. Zielke RA; Wierzbicki IH; Baarda BI; Gafken PR; Soge OO; Holmes KK; Jerse AE; Unemo M; Sikora AE Mol Cell Proteomics; 2016 Jul; 15(7):2338-55. PubMed ID: 27141096 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of gonococcal iron transport systems as potential vaccine antigens. Cornelissen CN Future Microbiol; 2008 Jun; 3(3):287-98. PubMed ID: 18505395 [TBL] [Abstract][Full Text] [Related]
19. Problems posed by potential gonococcal vaccines viewed from the vantage point of a control agency. Robbins JB Br J Vener Dis; 1977 Jun; 53(3):170-2. PubMed ID: 406011 [TBL] [Abstract][Full Text] [Related]
20. Vaccine research for gonococcal infections: where are we? Jerse AE; Deal CD Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv63-8. PubMed ID: 24243883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]